Tigo, Merasol .

HRN: 13-38-73  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2024
CEFTRIAXONE 1G (VIAL)
03/13/2024
03/19/2024
IV
2g
OD
CAP MR
Waiting Final Action 
03/13/2024
AZITHROMYCIN 500MG TABLET (TAB)
03/13/2024
03/17/2024
ORAL
500mg
OD
CAP Mr
Waiting Final Action 
03/19/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
03/19/2024
03/19/2024
IV
80mg
Now
IJ Catheter Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: